Skip to content Skip to footer
Subscribe Now
NEWS

Zealand Pharma Reports CHMP Positive Opinion for Zeydovio (Glepaglutide) for Short Bowel Syndrome (SBS)

Shots: The CHMP has recommended Zeydovio (glepaglutide) for the treatment of adults with SBS. Zealand is pursuing partnerships for the future global commercialization of Zeydovio for SBS Opinion was based on the P-III (EASE-1) trial of Zeydovio (10mg, QW or Q2W) vs PBO in 106 SBS pts with intestinal failure (IF), dependent on parenteral support…
September 18, 2026

Read more

INSIGHTS+

The US FDA New Drug Approvals in August 2026

Shots:  The US FDA approved seven novel therapies in August 2026, spanning rare diseases, oncology, neurology, hematology, and autoimmune disorders, including Orzeyful (oveporexton), Tauklarify (florquintau F 18), Zenbexus (iberdomide), Pasatru (garetosmab-grts), Rasonque (daraxonrasib), LISRAYA (brepocitinib), and Mimrylo (rusfertide).   Key approvals introduced new treatment options across multiple high-unmet-need indications, including narcolepsy type 1, Alzheimer’s disease imaging, relapsed/refractory multiple myeloma, fibrodysplasia ossificans progressiva, metastatic pancreatic ductal adenocarcinoma, dermatomyositis, and polycythemia…
September 8, 2026

Read more

EVENTS

HLTH USA 2026 | November 15-18 | Las Vegas, NV

Healthcare is entering a new era shaped by artificial intelligence, digital transformation, consumer-focused care, and rapid innovation across the healthcare ecosystem. As industry leaders look for new ways to improve outcomes, enhance access, and build a more connected healthcare system, HLTH USA 2026 will bring together the people and ideas driving this transformation. Taking place…
September 1, 2026

Read more

EVENTS

11th Edition Medical Device Project and Portfolio Management | November  11  –  12, 2026 | Chicago, IL

The Marcus Evans 11th Edition Medical Device Project and Portfolio Management conference will explore how MedTech leaders across portfolio, R&D & regulatory to translate strategy into measurable business outcomes. Sessions will explore responsible AI, capacity and capability planning, single-source-of-truth ecosystems, and Strategic Realization Offices that close the gap between executive expectations and delivery reality while…
August 31, 2026

Read more

EVENTS

Pharma Supply Chain & Security World 2027 | 03-04 March | London, United kingdom

The pharmaceutical supply chain is facing a rapidly changing environment shaped by global disruptions, evolving regulatory requirements, increasing product complexity, cybersecurity risks, and growing demands for speed and resilience. As companies look to strengthen their operations, building supply chains that are agile, responsive, streamlined, and secure has become a strategic priority. Against this backdrop, Pharma…
August 24, 2026

Read more

EVENTS

Digi-Tech Pharma & AI 2027 | May 11-12 | London, UK

The pharmaceutical and healthcare industries are entering a new era of technology-led transformation, with artificial intelligence, machine learning, data science, informatics, and advanced data management reshaping how medicines are discovered, developed, and delivered. Against this backdrop, Digi-Tech Pharma & AI 2027 will bring together senior professionals, technology leaders, decision-makers, and innovators from the pharmaceutical, biotechnology,…
August 19, 2026

Read more

EXCLUSIVE

Oncolytics Biotech’s Next Chapter: Jared Kelly on Advancing Pelareorep Toward Approval  

Shots  Pelareorep is gaining regulatory momentum through multiple FDA interactions and Fast Track designations, providing greater clarity around potential registration pathways and shaping Oncolytics’ clinical development and partnership strategy.  REO-033 could mark a pivotal step toward registration as the randomized study in RAS-mutant MSS metastatic colorectal cancer builds on encouraging clinical data and has the potential to become…
August 17, 2026

Read more

EVENTS

Global Clinical Trials Connect 2027 | May 11-12 | London, UK

As clinical trials become increasingly complex and technology-driven, the need for smarter strategies, stronger collaborations, and patient-centric innovation has never been greater. From decentralized clinical trials and artificial intelligence to advanced data management and evolving regulatory frameworks, the clinical research landscape is undergoing a significant transformation. Global Clinical Trials Connect 2027 aims to bring together…
August 6, 2026

Read more

EVENTS

BIOPLUS-INTERPHEX KOREA 2026 | October 28-30 | COEX, Seoul

BIOPLUS-INTERPHEX KOREA (BIX) 2026 is Korea's premier biopharmaceutical business event, bringing together global leaders across the entire biopharmaceutical value chain. Scheduled to take place from October 28-30, 2026, at COEX, Seoul, South Korea, the event serves as a platform for innovation, knowledge exchange, technology showcase, and strategic business partnerships. From drug discovery and clinical development…
August 5, 2026

Read more

Load more